XJSERHB
Market cap10mUSD
Dec 20, Last price
294.00ZAR
1D
0.00%
1Q
40.00%
IPO
-71.18%
Name
RH BOPHELO LIMITED
Chart & Performance
P/E
104.13
P/S
66.77
EPS
2.82
Div Yield, %
0.11%
Shrs. gr., 5y
4.90%
Rev. gr., 5y
63.35%
Revenues
285m
+3,735.27%
Net income
183m
P
CFO
-34m
L
Dividend
Dec 12, 202331 ZAR/sh
Earnings
May 26, 2025
Profile
RH Bophelo Limited invests in healthcare sector in South Africa. It primarily invests in equity, quasi-equity, and equity related investments in operational infrastructure, including health insurance, private hospital-related infrastructure, pharmaceuticals, and retail and distribution sectors. The company was incorporated in 2016 and is based in Johannesburg, South Africa. RH Bophelo Limited is a subsidiary of Public Investment Corporation SOC Limited.
Valuation
Title ZAR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑02 | 2023‑02 | 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | 2017‑02 | |
| Income | ||||||||
Revenues | 284,856 3,735.27% | 7,427 -75.16% | 29,898 108.25% | |||||
Cost of revenue | 12,273 | 5,526 | (48,096) | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 272,583 | 1,901 | 77,994 | |||||
NOPBT Margin | 95.69% | 25.59% | 260.87% | |||||
Operating Taxes | 49,568 | (12,397) | 10,948 | |||||
Tax Rate | 18.18% | 14.04% | ||||||
NOPAT | 223,015 | 14,297 | 67,046 | |||||
Net income | 182,644 -666.99% | (32,213) -160.23% | 53,484 -59.24% | |||||
Dividends | (20,054) | (13,604) | ||||||
Dividend yield | 7.77% | 4.13% | ||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 22,578 | 103,320 | 714 | |||||
Long-term debt | 52,308 | 3,729 | 5,255 | |||||
Deferred revenue | (561) | (630) | ||||||
Other long-term liabilities | 561 | 630 | ||||||
Net debt | (1,072,868) | (861,326) | (923,795) | |||||
| Cash flow | ||||||||
Cash from operating activities | (33,831) | 10,283 | 3,762 | |||||
CAPEX | (80) | (46) | ||||||
Cash from investing activities | (12,358) | 34,784 | (16,201) | |||||
Cash from financing activities | (51,011) | 99,100 | (14,496) | |||||
FCF | 211,072 | 5,305 | 68,428 | |||||
| Balance | ||||||||
Cash | 54,730 | 151,930 | 7,764 | |||||
Long term investments | 1,093,024 | 816,445 | 921,999 | |||||
Excess cash | 1,133,511 | 968,004 | 928,268 | |||||
Stockholders' equity | 1,034,333 | 871,744 | 903,957 | |||||
Invested Capital | 73,439 | 104,692 | 2,984 | |||||
ROIC | 250.39% | 26.56% | 2,024.35% | |||||
ROCE | 22.46% | 0.18% | 7.99% | |||||
| EV | ||||||||
Common stock shares outstanding | 64,691 | 64,691 | 64,691 | |||||
Price | 3.99 | 5.09 -36.38% | ||||||
Market cap | 258,118 | 329,279 -31.76% | ||||||
EV | (814,749) | (594,516) | ||||||
EBITDA | 273,492 | 2,790 | 78,876 | |||||
EV/EBITDA | ||||||||
Interest | 20,114 | 7,033 | 237 | |||||
Interest/NOPBT | 7.38% | 369.99% | 0.30% | |||||